Best Biotech Stocks To Invest In 2018


Ionis Pharmaceuticals (NASDAQ:IONS) is a biotech company which develops RNA-targeted therapeutics and has been operating for over 26 years. The company has recently filed to spin-off its Akcea Therapeutic segment, focused on Volanesorsen and other drugs related to cardiometabolic diseases originated by lipid disorders.

Ionis Core, the company core segment, has developed a broad pipeline of drugs for the company and its partners.

Ionis has been recently in the news following its spinning off of the Akcea segment. Akcea is going to raise $100 million from its IPO and Novartis, already a partner, will at the same time add $50 million of equity investment.


This strategic decision has puzzled many analysts, as it reduces Ionis Pharma’s opportunity to profit from the successes of the Akcea division. The official explanation for such spin-off is fresh money to commercialize Akcea’s main drug (Volanesorsen) and more investments towards research for new product s.

It is not yet clear what is the stake Ionis is going to keep in Akcea after the IPO.

Best Biotech Stocks To Invest In 2018: Capstead Mortgage Corporation(CMO)

Advisors’ Opinion:

  • [By Amanda Alix]

    As the spread between short-term and long-terminterest rates began to contract, strangling profits, competition for MBSes also caused prices to rise. Other agency mREITs were nervous, too. CYS Investments (NYSE: CYS  ) noted at the time that QE3 turned the Federal Reserve into the sector’s biggest rival for mortgage bonds, and as spreads began to shrink, so did dividends. By December of last year, Annaly, Armour, and Capstead Mortgage (NYSE: CMO  ) had all trimmed their payouts.

Best Biotech Stocks To Invest In 2018: EchoStar Corporation(SATS)


Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Incidentally, Facebook has secured shareholder approval for issuing Class C share at its shareholder meeting in June 2016, although it is yet to issue the shares.

    Other Companies With Dual-class Voting Shares Berkshire Hathaway Inc. (NYSE: BRK-A) and (NYSE: BRK-A), with Class A shares having 1/10th interest in the company but only 1/200th of voting power. Echostar Corporation (NASDAQ: SATS)’s CEO Charlie Ergen owns a 43.4 percent stake in the company through his holding of Class B shares but has 63.6 percent of the voting rights. Ford Motor Company (NYSE: F) uses the dual-class structure to give its founding family more voting power.


    Related Links:

Best Biotech Stocks To Invest In 2018: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Earlier this month, cannabis-focused financing and advisory firm iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF) announced it acquired Westchester-based Valley Agriceuticals, LLC, gaining access to New York’s nascent cannabis market.

  • [By Javier Hasse]

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

    “This was also to accelerate expansion within Colorado and going into other states nation-wide.”

    Valens Groworks Corp (CNSX: VGW), a Canadian post-inspection applicant for cannabis cultivation and processing, raised C$500,000 ($381,431) under a convertible note to meet acquisition and expansion obligations.

  • [By Javier Hasse]

    Over the past few weeks, Benzinga has been sharing interviews with the top venture capital and investment firms operating in the cannabis industry. Among those focused on ancillary businesses that do not touch the plant, we profiled Snoop Dogg’s Casa Verde and Arcview Group partner, CanopyBoulder. Among those willing to get involved in plant-touching ventures, we presented MJIC, which claims it intends to become the “Amazon.com, Inc. (NASDAQ: AMZN) of weed,” and iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF), which raises capital for U.S.-based marijuana companies in Canadian capital markets.

Leave a Reply

Your email address will not be published. Required fields are marked *